Sun Pharmaceutical (SUNPHARMA) — Corporate Action

Sun Pharmaceutical's Composite Scheme of Arrangement became effective on 22 November 2025 following National Company Law Tribunal approval. The certified order was filed with the Registrar of Companies, completing the regulatory process. The scheme's specific terms—including any demerger, merger, or restructuring components and shareholder impact—are not detailed in this intimation notice.

📄 View Original Announcement (PDF)

📊 Stock Analysis — SUNPHARMA ✨ Ask AI About This

About Sun Pharmaceutical Industries Limited (SUNPHARMA)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹4,50,643.09 Cr P/E: 41.3 ROE: 15.1% ROCE: 20.3%

View full SUNPHARMA stock details →

📡 Get AI alerts when SUNPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SUNPHARMA — Free

💡 Ask AI about this filing

"How does this corporate action affect Sun Pharmaceutical Industries Limited's outlook?" "What did Sun Pharmaceutical Industries Limited announce on 22 November 2025?" "Is this positive or negative for SUNPHARMA?"

Ask AI Free →

📊 More SUNPHARMA filings

See all SUNPHARMA filings →

🔥 Also filed on 22 November 2025

TATASTEEL Tata Steel Limited Announcement ICICIPRULI ICICI Prudential Life Insurance Company Limited Buyback / Redemption ICICIPRULI ICICI Prudential Life Insurance Company Limited Board Meeting MOTHERSON Samvardhana Motherson International Limited Voting Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when SUNPHARMA files new disclosures

Track SUNPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.